Regional Cancer Therapy

  • Peter M. Schlag
  • Ulrike Stein
  • Alexander M. M. Eggermont

Part of the Cancer Drug Discovery and Development book series (CDD&D)

Table of contents

  1. Front Matter
    Pages i-xiv
  2. Background

    1. Front Matter
      Pages 1-1
    2. Ulrike S. Stein, Wolfgang Walther, Peter M. Schlag
      Pages 3-18
    3. Hans Gelderblom, Joost Rothbarth, Cornelius J. H. van de Velde, Henk-Jan Guchelaar
      Pages 19-28
    4. Timo L. M. ten Hagen, Alexander M. M. Eggermont
      Pages 29-44
  3. Techniques and Prerequisites for Regional Therapy

    1. Front Matter
      Pages 45-45
    2. Enrique Lopez Hänninen, Timm Denecke
      Pages 47-58
    3. Sandra Grünberg, Peter M. Schlag
      Pages 59-72
    4. Peter Wust, Johanna Gellermann
      Pages 73-90
    5. Eren Berber, Allan E. Siperstein
      Pages 91-100
    6. Tristan D. Yan, Faruque Riffat, David L. Morris
      Pages 101-115
    7. Thomas J. Dougherty
      Pages 117-132
    8. Robert F. Wong, Amanjit S. Gill, Manoop S. Bhutani
      Pages 133-162
    9. Svetlana Gelperina
      Pages 163-179
    10. Wolfgang Walther, Ulrike S. Stein, Peter M. Schlag
      Pages 181-196
  4. Indications and Results for Different Tumor Entities

    1. Front Matter
      Pages 197-197
    2. Rebecca Taylor, James Tomlinson, Nancy Kemeny
      Pages 199-228
    3. Giuseppe Garcea, David P. Berry
      Pages 229-267
    4. Yehuda Skornick, Paul H. Sugarbaker
      Pages 269-282
    5. David P. Mangiameli, Steven K. Libutti, James F. Pingpank, H. Richard Alexander
      Pages 283-302

About this book

Introduction

Regional cancer therapies remain important options in the management of malignant disease, in spite of the venue of more targeted agents for systemic therapies. New te- nologies and better guidance systems for radiofrequency ablation and intrastitial laser therapies, highly selective intravascular approaches with improved catheters and gu- ance systems, improved agents for embolizations, and new vasoactive drugs for isolated limb and liver perfusions are just a few of the new developments in a field that is alive and progressing. Regional Cancer Therapy, so well put together by the editors Peter M. Schlag and Ulrike S. Stein, presents an overview of today’s realities and tomorrow’s possibilities. Regional cancer therapy models provide ways to make new discoveries about tumor biology and new agents that may be used regionally as well as systemically. This book should therefore be of interest to all clinicians and scientists with an interest in tumor biology as well as clinical advances. Alexander M. M. Eggermont, MD, PhD Professor and Head of Surgical Oncology Erasmus University MC—Daniel den Hoed Cancer Center Rotterdam, the Netherlands v PREFACE The treatment of malignant tumors has been substantially improved in recent years due to developments in clinical medicine and technology as well as by advances in mole- lar biological research. Modern molecular and genetic techniques allow the charact- ization of molecules that are decisive for tumor development and progression.

Keywords

Laboratory Tumor gene therapy liver tumor positron emission tomography ultrasound

Editors and affiliations

  • Peter M. Schlag
    • 1
    • 2
  • Ulrike Stein
    • 3
    • 2
  • Alexander M. M. Eggermont
    • 4
  1. 1.Robert-Rössle-Hospital and Tumor InstituteCharité University of MedicineBerlin
  2. 2.Max-Delbrück-Center for Molecular MedicineBerlinGermany
  3. 3.Tumor Metastasis and Therapy Response Program, Robert-Rössle-Hospital and Tumor InstituteCharité University of MedicineBerlin
  4. 4.Erasmus University MC—Daniel den Hoed Cancer CenterRotterdamThe Netherlands

Bibliographic information

  • DOI https://doi.org/10.1007/978-1-59745-225-0
  • Copyright Information Humana Press Inc., Totowa, NJ 2007
  • Publisher Name Humana Press
  • eBook Packages Medicine
  • Print ISBN 978-1-58829-672-6
  • Online ISBN 978-1-59745-225-0
  • About this book